Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2005Cancer Research

The Effect of Bcrp1 (Abcg2) on the In vivo Pharmacokinetics and Brain Penetration of Imatinib Mesylate (Gleevec): Implications for the Use of Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib in Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

PBPauline BreedveldDPDick PluimGCGreta Cipriani

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Breedveld et al. (2005) studied this question.

synapsesocial.com/papers/6a879cd6ee689f68de26180ahttps://doi.org/10.1158/0008-5472.can-04-2416
View Full Paper
Ask AI
Bookmark
Share